July 18, by ssw3an virginia.
cancer Department grants defense breast of
Furthermore, novel therapies capable of eliminating or terminally differentiating the breast cells carrying the genetic changes predisposing to malignancy could be developed. Erica Goddard and Mark Headley will use their awards to study how breast cancer cells spread to distant organs — and how to stop them. Studies of disability prevention are also essential for maximizing the breast cancer survivor's ability to participate in valued social roles and activities. Breast cancer is the most commonly diagnosed non-skin cancer in women. BOX 1.
A Review of the Department of Defense's Program for Breast Cancer Research.
Recommendations Related to Program Achievement and Management 1. Breast cancer is the most common malignancy among women and the second leading cause of cancer deaths in women in the United States.